1. Home
  2. NAOV vs ATCH Comparison

NAOV vs ATCH Comparison

Compare NAOV & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAOV
  • ATCH
  • Stock Information
  • Founded
  • NAOV 2003
  • ATCH 2022
  • Country
  • NAOV United States
  • ATCH United States
  • Employees
  • NAOV N/A
  • ATCH N/A
  • Industry
  • NAOV Industrial Specialties
  • ATCH
  • Sector
  • NAOV Health Care
  • ATCH
  • Exchange
  • NAOV Nasdaq
  • ATCH Nasdaq
  • Market Cap
  • NAOV 2.4M
  • ATCH 2.8M
  • IPO Year
  • NAOV N/A
  • ATCH N/A
  • Fundamental
  • Price
  • NAOV $0.92
  • ATCH $0.18
  • Analyst Decision
  • NAOV
  • ATCH
  • Analyst Count
  • NAOV 0
  • ATCH 0
  • Target Price
  • NAOV N/A
  • ATCH N/A
  • AVG Volume (30 Days)
  • NAOV 3.0M
  • ATCH 1.7M
  • Earning Date
  • NAOV 08-13-2025
  • ATCH 08-27-2025
  • Dividend Yield
  • NAOV N/A
  • ATCH N/A
  • EPS Growth
  • NAOV N/A
  • ATCH N/A
  • EPS
  • NAOV N/A
  • ATCH 2.67
  • Revenue
  • NAOV $2,662,000.00
  • ATCH N/A
  • Revenue This Year
  • NAOV N/A
  • ATCH N/A
  • Revenue Next Year
  • NAOV N/A
  • ATCH N/A
  • P/E Ratio
  • NAOV N/A
  • ATCH $0.07
  • Revenue Growth
  • NAOV N/A
  • ATCH N/A
  • 52 Week Low
  • NAOV $0.67
  • ATCH $0.17
  • 52 Week High
  • NAOV $16.25
  • ATCH $28.14
  • Technical
  • Relative Strength Index (RSI)
  • NAOV 40.36
  • ATCH 37.57
  • Support Level
  • NAOV $0.89
  • ATCH $0.18
  • Resistance Level
  • NAOV $1.08
  • ATCH $0.19
  • Average True Range (ATR)
  • NAOV 0.07
  • ATCH 0.01
  • MACD
  • NAOV 0.03
  • ATCH 0.00
  • Stochastic Oscillator
  • NAOV 52.29
  • ATCH 19.15

About NAOV NanoVibronix Inc.

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.

About ATCH AtlasClear Holdings Inc. Common Stock

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

Share on Social Networks: